Russian Federation
Russian Federation
This review analyzes scientific researches of clinical significance of the N-terminal pro-brain natriuretic peptide hormone (NT-proBNP) indicator for determining the risk of cardiovascular events in persons with prediabetes. The term «prediabetes» characterizes an intermediate state of metabolism dysregulation between the proper glucose homeostasis and diabetes. It points at the high risk of subsequent developing type 2 diabetes.
prediabetes, N-terminal pro-brain natriuretic peptide hormone, hyperglycemia
1. Global'nyy doklad po diabetu // Zheneva: Vsemirnaya organizaciya zdravoohraneniya. – 2018. Licenziya: CC BY-NC-SA 3.0 IGO.
2. Federal'naya sluzhba gosudarstvennoy statistiki. Zdravoohranenie v Rossii 2021 g. Publikaciya ot 03.02.2022. https://rosstat.gov.ru/folder/210/document/13218
3. Dedov I.I., Shestakova M.V., Mayorov A.Yu. (red.). Algoritmy specializirovannoy medicinskoy pomoschi bol'nym saharnym diabetom. Vyp. 9 // Saharnyy diabet. – 2019; 22(1S1):1– 144. https://doi.org/10.14341/DM221S1
4. Dedov I.I. i dr. Algoritmy specializirovannoy medicinskoy pomoschi bol'nym saharnym diabetom / Pod redakciey I.I. Dedova, M.V. Shestakovoy, A.Yu. Mayorova. 11-y vypusk // Saharnyy diabet. – 2023; 26 (2S):1-157
5. Garber A.J., Handelsman Y., Einhorn D., Bergman D.A., Bloomgarden Z.T., Fonseca V. et al. Diagnosis and Management of Prediabetes in the Continuum of Hyperglycemia: When Do the Risks of Diabetes Begin? A Consensus Statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists // Endocr Pract. – 2008; 14(7):933–946. https:// doi.org/10.4158/EP.14.7.933
6. Morgunova T.B., Glinkina I.V., Fadeev V.V. Preddiabet: problemy i puti resheniya // Medicinskiy sovet. – 2021; (12):220–227. https://doi.org/10.21518/2079-701X-2021-12-220-227
7. International diabetes federation. IDF diabetes atlas - 12th edition; 2021. R.1-135.
8. Cai X., Zhang Y., Li M., Wu J.H.Y., Mai L., Li J. et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis // BMJ. – 2020; 370: m2297. https://doi.org/10.1136/bmj.m2297
9. Francis G.S., Felker G.M., Tang W.H. A test in context: critical evaluation of natriuretic peptide testing in heart failure // J Am Coll Cardiol. – 2016; 67(3):330–7.
10. Gori M., Gupta D.K., Claggett B., Selvin E., Folsom A.R., Matsushita K. et al. Natriuretic peptide and high-sensitivity troponin for cardiovascular risk prediction in diabetes: the atherosclerosis risk in communities (ARIC) study // Diabetes Care. – 2016; 39(5): 677–685. Doi:https://doi.org/10.2337/dc15-1760
11. Marco Witkowski, Yuping Wu, W.H. Wilson Tang. NT-proBNP and cardiovascular event risk in individuals with prediabetes undergoing cardiovascular evaluation // Diabetes Res Clin Pract. – 2023: 205:110923. Doi:https://doi.org/10.1016/j.diabres.2023.110923
12. Liu H.H., Cao Y.X., Jin J.L., Guo Y.L., Zhu C.G., Wu N.Q., Gao Y., Zhang Y., Xu R.X., Dong Q., Li J.J. Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study // Cardiovasc Diabetol. – 2021 Apr 22; 20(1):84. Doi:https://doi.org/10.1186/s12933-021-01271-0
13. Wang J.L., Guo C.Y., Li H.W., Zhao X.Q., Zhao S.M. Prognostic Value of NT-proBNP in Patients With Successful PCI for ACS and Normal Left Ventricular Ejection Fraction // Am J Med Sci. – 2022; 363(4): 333-341. Doi:https://doi.org/10.1016/j.amjms.2021.10.017
14. Pareek M. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications // Dan Med J. – 2017; 64(9): B5400.
15. Nunes, S., Soares, E., Fernandes, J. et al. Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker // Cardiovasc Diabetol. – 2013; 12: 44. https://doi.org/10.1186/1475-2840-12-44
